Jan Vishwas Act 2026: Balancing Ease of Doing Business with Public Health Integrity
GS2GS4
The Union Government has operationalized the Jan Vishwas Act 2026, introducing a trust-based regulatory framework that decriminalizes minor procedural lapses in the food and drug sectors while maintaining strict penalties for serious public health violations.
The Union Government’s operationalization of the Jan Vishwas Act 2026 represents a landmark shift in India’s regulatory philosophy, moving from a culture of suspicion to one of "trust-based governance." By specifically targeting the food and drug sectors, the Act addresses a long-standing grievance of the industry: the criminalization of minor, non-harmful procedural errors that often led to protracted legal battles and hindered economic growth.
The core of this reform lies in the nuanced distinction between technical lapses—such as minor labeling errors or record-keeping delays—and serious public health offences like the manufacturing of spurious drugs or adulterated food. For the former, the Act replaces imprisonment with monetary penalties, thereby reducing the "inspector raj" and the fear of arbitrary litigation. For the latter, however, the government maintains a zero-tolerance policy, ensuring that the ethical mandate to protect citizen health is not compromised. This proportionate enforcement mechanism aims to foster a more conducive environment for the pharmaceutical and food processing industries, which are critical to India's export economy.
Continue reading — free with login
JeetoBharat publishes daily UPSC current affairs mapped to the Mains syllabus. Log in to read full articles.
Log in to read full articleNo credit card required. Free registered users get unlimited access.
This article was curated using AI. While we strive for accuracy, please verify critical facts from official sources.